Machine learning in antiviral drug design.

Area of Science:

• Virology
• Computational Chemistry
• Drug Discovery

Background:

• Viral infections represent a significant global health challenge.
• Developing effective antiviral therapies is difficult due to viral mutation and host cell reliance.
• Traditional antiviral drug development is slow and expensive, necessitating faster methods.

Purpose of the Study:

• To review the application of machine learning (ML) in early-stage antiviral drug discovery.
• To highlight successful ML methodologies in identifying novel antiviral hit compounds.
• To illustrate the impact of ML on advancing the discovery of new antivirals.

Main Methods:

• Review of recent studies applying ML/AI in antiviral drug discovery.
• Focus on ML methods identifying hit compounds with experimental validation.
• Analysis of case studies demonstrating ML's efficacy.

Main Results:

• ML methods have successfully identified hit compounds with demonstrated antiviral activity.
• Successful case studies showcase the practical application of ML in drug discovery.
• ML significantly accelerates the identification of potential antiviral agents.

Conclusions:

• Machine learning is a powerful tool for accelerating antiviral drug discovery.
• AI-driven approaches offer a more efficient pathway to novel antiviral therapies.
• ML's impact is growing, aiding the development of urgently needed antivirals.